Abilify Asimtufii (aripiprazole) is prescribed to help treat schizophrenia and bipolar I disorder. The drug comes as a suspension (a liquid mixture) that a healthcare professional injects into a ...
Aripiprazole 10mg, 15mg; vanilla flavor; contains phenylalanine. Orally disintegrating tabs: Dissolve on tongue; take without liquids. Bipolar disorder: initially 15mg once daily; may increase to max ...
ABILIFY tablets are available in 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg strengths. The effective dose range is 10-30 mg/day for schizophrenia patients, and 15 or 30 mg/day for Bipolar I Disorder ...
Aripiprazole Tablets are indicated for the treatment of schizophrenia and the acute treatment of manic and mixed episodes associated with bipolar I disorder. Lupin has received the Food and Drug ...
PRINCETON, NJ and TOKYO, JAPAN, November 20, 2007 – Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) ...
TORONTO, Sept. 10, 2018 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announces that the complete line of Pr Teva-Aripiprazole (2 mg, 5 mg, 10 mg, 15 mg, 20 mg and ...
The FINANCIAL — Teva Pharmaceutical Industries Ltd., on April 28 announced the launch of the generic equivalent to Abilify (aripiprazole) Tablets, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg, in the ...
Abstract and Introduction Clinical Profile of Aripiprazole as Reflected by Clinical Trial Data Use of Aripiprazole in the Treatment of Schizophrenia: Consensus Report Conclusion References Control of ...
Co confirmed that it has initiated a challenge of the patent listed by Otsuka Pharmaceutical Co., Ltd in connection with its Abilify (aripiprazole) tablets, 2mg, 5mg, 10mg, 15mg, 20mg & 30mg.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results